ProCE Banner Activity

Overview of HER2 and Treatment of HER2-Positive Early Breast Cancer


Download these slides from an expert-led webinar on the latest data for the treatment of HER2-positive early breast cancer.

Released: February 28, 2023



Aditya Bardia

Aditya Bardia, MD, MPH

Director, Breast Cancer Research
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

Erika P. Hamilton

Erika P. Hamilton, MD

Director, Breast Cancer Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from Puma Biotechnology, Inc. and Seagen Inc.

Puma Biotechnology, Inc.

Seagen Inc.